Clinical Trials Sponsored by Clinartis

Total 13 results

Wockhardt
Clinartis

Completed

Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

Intrapulmonary Pharmacokinetics of WCK 2349

United States
Wockhardt
Clinartis

Completed

To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment

Renal Impairment

United States
Wockhardt
Clinartis

Completed

A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment

Renal Impairment

United States
Wockhardt
Clinartis

Completed

Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human Subjects

Healthy

United States
Wockhardt
Clinartis, LLC

Completed

To Investigate the Multiple Dose Safety, Tolerability and Pharmacokinetics of WCK 4282 (FEP-TAZ)

Antibiotics Causing Adverse Effects in Therapeutic Use

United States
Entasis Therapeutics
Clinartis

Completed

Study to Determine and Compare Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Subjects

Healthy

United States
Spero Therapeutics
Clinartis

Completed

Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers

Healthy Volunteers

United States
Wockhardt
Clinartis, LLC; Keystone Bioanalytical, Inc.

Completed

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin

Healthy

United States
Ligartis GmbH

Withdrawn

Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO) (JaNEO)

Bladder Cancer

Germany
AstraZeneca
Clinart International

Completed

Centralized Pan-Middle East Survey on the Under-treatment of Hypercholesterolemia, Sub-study for the Gulf States (CEPHEUS)

Hypercholesterolemia

United Arab Emirates
Institute for Molecular Medicine
National Institute on Aging (NIA); Clinartis

Recruiting

Study of AV-1959, an Amyloid Beta Vaccine

Alzheimer Disease

United States
Danisco
Almarai; Clinart International

Terminated

Vetal Laban Intervention Trial Assessing Bowel Symptoms (KF_2013)

Irritable Bowel Syndrome

Saudi Arabia
AstraZeneca
ClinArt Company & Signen Clinical Discoveries

Completed

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia (CEPHEUS)

Hypercholesterolemia

Saudi Arabia

3

Subscribe